Insulet earnings were $428.8M for the trailing 12 months ending Sep 30, 2026, with 75.4% growth year over year. The latest PODD earnings report on Sep 30, 2026 announced Q3 2026 earnings of $141.1M, up 48.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PODD reported annual earnings of $247.1M, with -40.9% growth.
PODD past earnings growth
How has PODD's earnings growth performed historically?
On PODD's earnings call on Nov 4, 2026, Insulet (NASDAQ: PODD) reported Q3 2026 earnings per share (EPS) of $2.03, up 63.71% year over year. Total PODD earnings for the quarter were $141.10 million. In the same quarter last year, Insulet's earnings per share (EPS) was $1.24.
As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $428.80 million, a 74.17% increase year over year.
What was PODD's earnings growth in the past year?
As of Insulet's earnings date in Nov 4, 2026, Insulet's earnings has grown 75.43% year over year. This is 79.04 percentage points higher than the US Medical Devices industry earnings growth rate of -3.61%. PODD earnings in the past year totalled $428.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.